Patients in the ICU often receive extra oxygen, but both too much and too little can be harmful. The same applies to blood thinners and painkillers. Agreements on minimum and maximum doses give doctors guidance. However, research by Imeen van der Wal shows it’s important that healthcare providers don’t blindly follow these limits and can adjust treatment when needed.
Read more&width=710&height=710)
Introduction
LUMC strongly underpins the idea that ‘Science is the driving force behind innovative healthcare’. Outcomes of top level fundamental, translational and clinical research by LUMC researchers form a strong basis for innovative and qualitative healthcare on a national, European and international level.
A real game changer was the development of the Dutch national research agenda (NWA) in 2015. The agenda reveals the complexity of the issues challenging Dutch society today. These issues are clustered in so called routes. LUMC is involved in many of these routes and contributes this way to solving important societal challenges.